MTNB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Matinas BioPharma Holdings Inc

Watchlist Manager

Watchlist

Price: 2.53 USD 1 481.25% Market Closed

Market Cap: $34.6m

M	Matinas BioPharma Holdings Inc AMEX:MTNB	US
G	General Motors Co BMV:GM	US
A	American International Group Inc XHAM:AINN	US
	BNP Paribas SA PAR:BNP	FR
T	Texas Instruments Inc XMUN:TII	US
M	Mayfair Gold Corp XTSX:MFG	CA
	Property Franchise Group PLC LSE:TPFG	UK
E	EchoStar Corp F:E20	US
	Biontech SE NASDAQ:BNTX	DE
U	Unite Group PLC XMUN:U1B	UK
W	Wealth Minerals Ltd OTC:WMLLF	CA
A	Alstom SA F:AOMD	FR
	Peet Ltd ASX:PPC	AU
	Sabaf SpA MIL:SAB	IT
P	Palantir Technologies Inc F:PTX	US

Profitability Summary

Matinas BioPharma Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-1 625%

Low Net Margin

Negative 3Y Average Net Margin

-1 539%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1 060%

Negative ROE

-140%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-195%

ROIC is Increasing

-187% > -123%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.